Managing drug-resistant essential menorrhagia without hysterectomy.
Menorrhagia is a common disorder that requires plenty of resources. Rapid developments in medical technology have resulted in new management strategies, which are true alternatives to hysterectomy. In many countries the levonorgestrel-releasing intrauterine system (LNG-IUS) and endometrial destruction techniques are available for menorrhagia. Clinicians must answer questions about cost, effectiveness and quality of medical care when choosing the treatment option. This review integrates the results from the latest studies and review articles about LNG-IUS and endometrial destruction techniques by addressing the key clinical issues in menorrhagia. Both LNG-IUS and endometrial ablation seem to be good and effective alternative options to hysterectomy. Although these treatments have relatively high failure rates, the majority of women are satisfied and the cost-effectiveness of these treatments are better than that of hysterectomy. Both treatments have their advantages and disadvantages. Thus far LNG-IUS seems to be more cost-effective than endometrial resection or hysterectomy at 5 years follow-up. However, second generation ablation techniques may offer better cost-effectiveness than the first generation techniques, but the evidence is insufficient.
Hurskainen
Ritva
R
Department of Obstetrics and Gynecology, Hyvinkää Hospital, Hospital District of Helsinki and Uusimaa, Sairaalank 1, 05850 Hyvinkää, Finland. ritva.hurskainen@hus.fi
D017115:Catheter Ablation / Q000191:economics; D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000191:economics; D003362:Cost-Benefit Analysis; D004351:Drug Resistance; D004717:Endometrium / Q000601:surgery; D019317:Evidence-Based Medicine; D005260:Female; D013509:Gynecologic Surgical Procedures / Q000191:economics / Q000379:methods; D006801:Humans; D007044:Hysterectomy; D007436:Intrauterine Devices, Medicated / Q000191:economics; D016912:Levonorgestrel / Q000008:administration & dosage / Q000191:economics; D008595:Menorrhagia / Q000191:economics / Q000628:therapy*; D016896:Treatment Outcome
D003271:Contraceptive Agents, Female; D016912:Levonorgestrel